Rituximab for the treatment of rheumatoid arthritis after the failure of conventional disease-modifying anti-rheumatic drugs [ID333]

  • Discontinued
  • GID-TAG418

Documents

Documents created during the development process.

Rheumatoid arthritis - rituximab: final scope

Rheumatoid arthritis - rituximab: final matrix

Rheumatoid arthritis - rituximab: response to comments on the draft scope

Appendix C - provisional matrix (pre-referral) - November 2009

Appendix B - draft scope for consultation (pre-referral) - November 2009